MULLER.BO(MULLER.BO)
MULLER.BO
$213.65—Stale · unknown old
BSE • Last print unknown ago
$213.65—Stale · unknown old
Muller & Phipps (India) Limited operates as a distribution company specializing in pharmaceuticals, consumer goods, and electronics across India. The company leverages its extensive network and logistics capabilities to serve a diverse client base, positioning itself as a key player in the industrial distribution sector.
Muller & Phipps generates revenue primarily through the distribution of pharmaceuticals and consumer goods, capitalizing on its established relationships with manufacturers and retailers. The company benefits from a broad geographic reach and a strong logistics framework, allowing it to maintain competitive pricing and efficient service delivery.
Changes in pharmaceutical regulations impacting distribution licenses
Fluctuations in consumer demand for healthcare products
Supply chain disruptions affecting inventory levels
Market share shifts among key competitors
Regulatory changes in the pharmaceutical sector that could impact distribution practices
Technological disruption in logistics and supply chain management
Increased competition from larger distribution firms with more resources
Emergence of e-commerce platforms reducing traditional distribution needs
Negative operating margins leading to potential liquidity issues
Low current ratio indicating potential short-term financial strain
moderate - The company's performance is linked to overall industrial activity and consumer spending, particularly in the healthcare sector.
Interest rates affect the company's financing costs and can influence consumer spending, impacting demand for its products.
minimal
value - Investors may be attracted by the potential for turnaround given the company's current low valuation metrics.
high - The stock has shown significant volatility with a 1-year return of -9.9%.